000 | 01089 a2200301 4500 | ||
---|---|---|---|
005 | 20250517154824.0 | ||
264 | 0 | _c20190523 | |
008 | 201905s 0 0 eng d | ||
022 | _a1527-7755 | ||
024 | 7 |
_a10.1200/JCO.2017.72.2629 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChoueiri, Toni K | |
245 | 0 | 0 |
_aReply to B. Rini et al and S. Buti et al. _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c06 2017 |
||
300 |
_a1859-1860 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aAnilides |
650 | 0 | 4 | _aCarcinoma, Renal Cell |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKidney Neoplasms |
650 | 0 | 4 | _aPyridines |
650 | 0 | 4 | _aSunitinib |
700 | 1 | _aHalabi, Susan | |
700 | 1 | _aMorris, Michael J | |
700 | 1 | _aGeorge, Daniel | |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 35 _gno. 16 _gp. 1859-1860 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2017.72.2629 _zAvailable from publisher's website |
999 |
_c27214573 _d27214573 |